(EMAILWIRE.COM, July 04, 2015 ) There are no marketed pharmacological therapies that are indicated for DMD. The current standard of care treatment involves generic corticosteroids which are used to marginally prolong muscle function but do not offer preventative treatment. The anticipated launch…
http://www.emailwire.com/release/191209-OpportunityAnalyzer-Duchenne-Muscular-Dystrophy-Opportunity-and-Market-Analysis-to-2019.html